{"id":"xuebijing-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Allergic reaction / hypersensitivity"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The injection contains active compounds from Carthamus tinctorius, Salvia miltiorrhiza, and Paeoniae radix that work through multiple mechanisms including inhibition of pro-inflammatory cytokines (TNF-α, IL-6), reduction of endotoxin-induced coagulation cascade activation, and improvement of microcirculation. It is used primarily in sepsis management to attenuate systemic inflammatory response and prevent disseminated intravascular coagulation.","oneSentence":"XueBiJing Injection is a traditional Chinese medicine-derived herbal extract that modulates inflammatory and coagulation pathways to reduce sepsis-related organ dysfunction.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:16:26.404Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Sepsis and septic shock"},{"name":"Systemic inflammatory response syndrome (SIRS)"},{"name":"Disseminated intravascular coagulation (DIC) associated with sepsis"}]},"trialDetails":[{"nctId":"NCT07069894","phase":"","title":"Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）","status":"NOT_YET_RECRUITING","sponsor":"Southeast University, China","startDate":"2025-08-01","conditions":"Sepsis","enrollment":5400},{"nctId":"NCT07026227","phase":"NA","title":"Effect of Xuebijing in Alleviating Acute Kidney Injury After High-voltage Electrical Burns","status":"COMPLETED","sponsor":"The First Hospital of Hebei Medical University","startDate":"2023-02-20","conditions":"Acute Kidney Injury","enrollment":96},{"nctId":"NCT06920420","phase":"","title":"Novel Biomarkers Related Xuebijing Injection Improves Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Southeast University, China","startDate":"2025-03-30","conditions":"Sepsis","enrollment":30},{"nctId":"NCT04993794","phase":"NA","title":"Additive Anti-inflammatory Action for Critically Ill Patients With Cardiovascular Surgery (Xuebijing) IV","status":"UNKNOWN","sponsor":"Nanjing Medical University","startDate":"2021-01-01","conditions":"Cardiovascular Disease, Aortic Dissection, Coronary Artery Disease","enrollment":200},{"nctId":"NCT03238742","phase":"PHASE4","title":"The Efficacy of Xuebijing Injection on Sepsis","status":"COMPLETED","sponsor":"Southeast University, China","startDate":"2017-10-20","conditions":"Sepsis","enrollment":1817},{"nctId":"NCT03475732","phase":"NA","title":"Pharmacokinetics of XueBiJing in Patients With Sepsis","status":"COMPLETED","sponsor":"Southeast University, China","startDate":"2018-03-18","conditions":"Sepsis, Septic Shock, Community Acquired Pneumonia","enrollment":35},{"nctId":"NCT02937974","phase":"PHASE4","title":"Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2016-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":254}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":270,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tianjin Chase Sun Pharmaceutical Co. LTD"],"phase":"marketed","status":"active","brandName":"XueBiJing Injection","genericName":"XueBiJing Injection","companyName":"Nanjing Medical University","companyId":"nanjing-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"XueBiJing Injection is a traditional Chinese medicine-derived herbal extract that modulates inflammatory and coagulation pathways to reduce sepsis-related organ dysfunction. Used for Sepsis and septic shock, Systemic inflammatory response syndrome (SIRS), Disseminated intravascular coagulation (DIC) associated with sepsis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}